1 |
ARMSTRONG A W, READ C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review[J]. JAMA, 2020, 323(19): 1945-1960.
|
2 |
BOLOTNA L, SARIAN O. Psychopathological disorders as comorbidity in patients with psoriasis (review)[J]. Georgian Med News,2020(301): 143-147.
|
3 |
REOLID A, MUÑOZ-ACEITUNO E, ABAD-SANTOS F, et al. Epigenetics in non-tumor immune-mediated skin diseases[J].Mol Diagn Ther,2021, 25(2): 137-161.
|
4 |
ZHANG J Y, YANG C, WU C F, et al. DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy[J]. Cancers (Basel), 2020, 12(8): E2123.
|
5 |
毛旭华, 栾 超, 胡 煜, 等. 寻常性银屑病患者表皮中DNA甲基化转移酶2和3a mRNA的表达[J]. 中华皮肤科杂志, 2018, 51(8): 607-608.
|
6 |
MORCIANO G, VEZZANI B, MISSIROLI S, et al. An updated understanding of the role of YAP in driving oncogenic responses[J]. Cancers(Basel),2021,13(12): 3100.
|
7 |
JIA J J, LI C J, YANG J, et al. Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway[J]. Sci Rep, 2018, 8(1): 14513.
|
8 |
WANG R, DU Y H, SHANG J, et al. PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling[J]. Mol Cell Probes, 2020, 53: 101642.
|
9 |
LADIZ M A R, NAJAFI M, KORDI-TAMANDANI D M.Contribution of LATS1 and LATS2 promoter methylation in OSCC development[J]. J Cell Commun Signal, 2017, 11(1): 49-55.
|
10 |
贾金靖, 莫秀梅, 刘俊峰, 等. 丹参素对银屑病样细胞Yes相关蛋白表达及细胞增殖、凋亡的影响[J]. 中华皮肤科杂志, 2020, 53(6): 452-458.
|
11 |
AUGUSTIN M, VALENCIA LÓPEZ M, REICH K. Network meta-analyses in psoriasis: overview and critical discussion[J]. J Eur Acad Dermatol Venereol, 2021, 35(12): 2367-2376.
|
12 |
WU Z M, GUAN K L. Hippo signaling in embryogenesis and development[J]. Trends Biochem Sci, 2021, 46(1): 51-63.
|
13 |
CHEN K H, HE J, WANG D L, et al. Methylation‑associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma[J]. Int J Oncol, 2014, 45(6): 2511-2521.
|
14 |
SHAO S, GUDJONSSON J. Epigenetics of psoriasis[J]. Adv Exp Med Biol, 2020, 1253: 209-221.
|
15 |
ZHANG P, ZHAO M, LIANG G P, et al. Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris[J].J Autoimmun,2013,41: 17-24.
|
16 |
GU X L, NYLANDER E, COATES P J, et al. Correlation between reversal of DNA methylation and clinical symptoms in psoriatic epidermis following narrow-band UVB phototherapy[J]. J Invest Dermatol, 2015, 135(8): 2077-2083.
|
17 |
HU C H, LIU X H, ZENG Y, et al. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application[J]. Clin Epigenetics, 2021, 13(1): 166.
|
18 |
HEGDE M, JOSHI M B. Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors[J].J Cancer Res Clin Oncol,2021,147(4): 937-971.
|
19 |
练 霓, 栾 超, 郝志敏, 等. 寻常性银屑病患者表皮中DNA总体甲基化水平检测[J]. 中国皮肤性病学杂志, 2020, 34(5): 519-523.
|
20 |
REN D Y, SUN Y, ZHANG D, et al. SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis[J]. Cancer Lett, 2021, 519: 277-288.
|
21 |
ZHAO D, XIA L, GENG W, et al. Metformin suppresses interleukin-22 induced hepatocellular carcinoma by upregulating Hippo signaling pathway[J]. J Gastroenterol Hepatol, 2021, 36(12): 3469-3476.
|
22 |
ZHU M, PENG R Q, LIANG X, et al. P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis[J]. Oncogene, 2021, 40(41): 6049-6056.
|
23 |
YANG X L, XU Y J, JIANG C, et al. Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway[J].Oncol Lett,2021,22(4): 724.
|